Patients with T2DM are more susceptible to the development of chronic anemia, which may be due to inadequate glycemic control, CKD (that leads to erythropoietin production decrease), presence of T2DM complications, or age >60 years [44,45,46]. Here, EPO is linked to type 2 diabetes mellitus.